PGFC
LABU icon

Peapack-Gladstone Financial Corp’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,600
Closed -$308K – 706
2023
Q2 		$308K Buy
+2,600
New +$324K 0.01% 564

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Peapack-Gladstone Financial Corp's LABU Position: Q3 2023 in Review

Peapack-Gladstone Financial Corp sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2023, closing a stake of 2,600 shares — an estimated $308K sold.

Peapack-Gladstone Financial Corp first reported a position in LABU in Q2 2023 and held it in 1 quarter. The position peaked at $308K in Q2 2023. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2023.

  • Peapack-Gladstone Financial Corp reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2023 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 2,600 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2023, an estimated $308K.
  • Peapack-Gladstone Financial Corp first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2023 and held it in 1 quarter.
  • Peapack-Gladstone Financial Corp's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $308K in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2023.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q3 2023, filed 14 Nov 2023.